[1] | Zhaoxia LI, Nan LI, Guijie XIN. Research advances in hepatitis B virus-associated glomerulonephritis[J]. Journal of Clinical Hepatology, 2023, 39(3): 651-656. doi: 10.3969/j.issn.1001-5256.2023.03.027 |
[2] | Wu XiaoLi. Influence of combination mode of PEG-IFNα-2a and adefovir dipivoxil on outcome of patients with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2017, 33(12): 2311-2315. doi: 10.3969/j.issn.1001-5256.2017.12.011 |
[3] | You Jia, Chen Jing, Ye QiaoXia, Zheng Qi, Zhu YueYong, Dong Jing, Liu YuRui, Jiang JiaJi. Efficacy of add- on adefovir dipivoxil at week 12 /24 in HBe Ag- positive chronic hepatitis B patients during PEG-IFNα therapy[J]. Journal of Clinical Hepatology, 2016, 32(4): 687-690. doi: 10.3969/j.issn.1001-5256.2016.04.015 |
[4] | Li Na, Gou Wei, Cui WeiLi. Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1714-1716. doi: 10.3969/j.issn.1001-5256.2016.09.015 |
[5] | An Shuang, Zhang Rui, Yang WenXuan, Zhou HongJie, Zhang ZeTian, Yang YiLiang, Guo XiaoLin. Research advances in hepatitis B virus-associated glomerulonephritis[J]. Journal of Clinical Hepatology, 2016, 32(2): 366-369. doi: 10.3969/j.issn.1001-5256.2016.02.037 |
[6] | Xiao ChunHua, Li XuHui, Zhang ChunLan, Jian XiYao. Efficacy of adefovir dipivoxil in treatment of chronic hepatitis B patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(2): 266-268. doi: 10.3969/j.issn.1001-5256.2015.02.029 |
[7] | Yang XiaoYan, Sun ZhangYu, Yuan Xiang, Liang YaLin. Clinical analysis of hypophosphatemia induced by adefovir dipivoxil in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(12): 2047-2050. doi: 10.3969/j.issn.1001-5256.2015.12.014 |
[8] | Zhang Wen, Yu JianGuo, Zhu GuiZhong, Zhao ZhanDong, Wang XiaoWei. Clinical efficacy of entecavir combined with adefovir in chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2014, 30(11): 1169-1172. doi: 10.3969/j.issn.1001-5256.2014.11.019 |
[9] | Huang MeiJin, Tan HouJi, He YanZhuan, Huang QiWen, Zhou YaoNan, Qiu HaiXian. Forty-eight-week efficacy of adefovir dipivoxil alone versus combined with lamivudine in treatment of lamivudine-resistant HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 636-638. doi: 10.3969/j.issn.1001-5256.2014.07.015 |
[10] | Zhang FengXiao, Bai XueSong. Therapeutic efficacy of Ganshuang granules in treatment of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(4): 317-319. doi: 10.3969/j.issn.1001-5256.2014.04.008 |
[11] | Ma YanHong. Clinical effect of initial combination therapy with lamivudine plus adefovir dipivoxil in 48-week treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2013, 29(8): 631-632. doi: 10.3969/j.issn.1001-5256.2013.08.020 |
[12] | Ruan BingWei, Lu XiaoJu, Lin YanMing, Chen RongCe, Chen XinZhi, Ceng GuangZhong, Liu YanPing. Evaluation of adverse reactions induced by adefovir dipivoxil in 85 chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2013, 29(2): 104-106. |
[13] | Wang LiPing, Han FangZheng, Li ChunYang, Yan Mei, Zhang YanChao, Yan XueBing. Evaluation of adefovir primary resistance and adefovir repulsive mutations of the HBV DNA P gene in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(8): 606-608. |
[14] | Zhao WenLi, Cheng Hong, Yang ZhongMin. Effects of combination therapy of matrine with adefovir dipivoxil on hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(5): 490-492. |
[15] | Qiu YingFeng, Ding YongGang, Li GuangMing. Analysis of therapeutic effect of adefovir dipivoxil in continued treatment of chronic hepatitis B patients with poor early virological response to initial treatment[J]. Journal of Clinical Hepatology, 2011, 27(6): 611-613. |
[16] | Zhu FeiYan. The clinical effect Adefovir dipivoxil in Lamivudine resistant HBeAg positive chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2010, 26(5): 517-518. |
[17] | Feng Fei, Ma Li, Cui HongLing, Liu JingFang. The Adefovir dipivoxil presses the liver cell growth hormone treatment chronic type B heavy hepatitis curative effect observation jointly[J]. Journal of Clinical Hepatology, 2010, 26(6): 594-595. |
[18] | Yang YaFang, Yang XiaoPing, Dong JianGuo, Wang ZhiGang, Liu YanPing, Zhao TieJun, Gao Feng. Analysis of short-term efficacy of entecavir and adefovir dipivoxil in the treatment of HBeAg-positive chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(3): 326-327. |